Matthew Winkler

North America, Texas, United States, Austin

Description

Matt Winkler is a Board Member at Akoya Biosciences.

Investor Profile

Matthew Winkler has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

Series B (100%)

Country Focus

United States (100%)

Industry Focus

Biotechnology
Health Diagnostics
Medical

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Matthew Winkler frequently co-invest with?

Pfizer Venture Investments

North America, New York, United States, New York

Co-Investments: 1

Lifeforce Capital

North America, California, United States, San Francisco

Co-Investments: 1

Mayo Clinic

North America, Minnesota, United States, Rochester

Co-Investments: 1

Digitalis Ventures

North America, New York, United States, New York

Co-Investments: 1

Adveq

Europe, Zurich, Switzerland, Zürich

Co-Investments: 1

Morgenthaler Ventures

North America, California, United States, Menlo Park

Co-Investments: 1

Roche Venture Fund

Europe, Basel-Stadt, Switzerland, Basel

Co-Investments: 1

Advanced Technology Ventures

North America, California, United States, Menlo Park

Co-Investments: 1

MBLVC

Asia, Aichi, Japan, Nagoya

Co-Investments: 1

Seraph Group

North America, Georgia, United States, Alpharetta

Co-Investments: 1

What are some of recent deals done by Matthew Winkler?

Second Genome

San Francisco, California, United States

Second Genome offers a pipeline of microbiome modulators that impact infection, immunity and metabolic diseases.

BiotechnologyHealth DiagnosticsMedical

Series BApr 13, 2016

Amount Raised: $51,000,000

Matthew Winkler

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Matthew Winkler frequently co-invest with?

What are some of recent deals done by Matthew Winkler?

Ready to Raise Capital?

Pages

Free tools